Xianbin Tian
- Oncology top 5%
- Pharmacology top 1%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Epidemiology
- Co-authors
- Kim L. R. BrouwerMaciej J. Zamek‐GliszczynskiKen-ichi NezasaThomas J. RaubNita PatelArlene S. BridgesPeijin ZhangMartin G. Belinsky
- Topics
- Drug Transport and Resistance Mechanisms (13 papers)Pharmacological Effects and Toxicity Studies (9 papers)Chronic Lymphocytic Leukemia Research (5 papers)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Xianbin Tian
33 papers receiving 957 citations
Peers
Comparison fields: 5 of 82
- Oncology 579
- Pharmacology 298
- Pediatrics, Perinatology and Child Health 291
- Molecular Biology 216
- Epidemiology 118
Countries citing papers authored by Xianbin Tian
This map shows the geographic impact of Xianbin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbin Tian more than expected).
Fields of papers citing papers by Xianbin Tian
This network shows the impact of papers produced by Xianbin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbin Tian. The network helps show where Xianbin Tian may publish in the future.
Co-authorship network of co-authors of Xianbin Tian
This figure shows the co-authorship network connecting the top 25 collaborators of Xianbin Tian. A scholar is included among the top collaborators of Xianbin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianbin Tian. Xianbin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 23 | |
| 5 | 23 | |
| 6 | 49 | |
| 7 | 6 | |
| 8 | 15 | |
| 9 | 15 | |
| 10 | 34 | |
| 11 | 37 | |
| 12 | 79 | |
| 13 | 65 | |
| 14 | 22 | |
| 15 | 74 | |
| 16 | 41 | |
| 17 | 88 | |
| 18 | 58 | |
| 19 | 54 | |
| 20 | 42 |
About Xianbin Tian
Xianbin Tian is a scholar working on Pharmacology, Oncology and Immunology and Allergy, having authored 33 papers that have together received 972 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Pharmacology (298 citations), Oncology (579 citations) and Pediatrics, Perinatology and Child Health (291 citations). Xianbin Tian has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Kim L. R. Brouwer, Maciej J. Zamek‐Gliszczynski, Ken-ichi Nezasa, Thomas J. Raub, Nita Patel, Arlene S. Bridges, Peijin Zhang, Martin G. Belinsky, Gary D. Kruh and J. Cory Kalvass. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.